BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 25.05.1994

Prospective Grant Of Partially Exclusive Licenses: Antisense Phosphorothioate Oligodeoxyribonucleotides

The National Institutes of Health (NIH) intends to grant partially exclusive licenses to ISIS Pharmaceuticals, Inc. and Hybridon, Inc. for antisense phosphorothioate oligodeoxyribonucleotides patent applications and patents.

Source: Federal Register — Health and Human ServicesOpen original release →